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Although the nature of epilepsy and headache association has 
not been full understand, during the past 100 years several potential 
mechanism have been proposed to explain the link between this 
two condition [1]. To get a definitive international consensus on the 
crossover between headache and epilepsy, many authors have spent 
endless efforts to reach an agreement on the various aspects of this 
intriguing concept.
The clinical hypothesis that headache and epilepsy are related 
derives from 19th century literature data. Sir Gowers first suggested 
that “migraine is in the borderland of epilepsy”, and we can say now, 
in the light of modern knowledge, that neurotransmitters and ion 
channel dysfunctions can play a leading role. Both are characterized by 
transient attacks of altered brain function with a spectrum of common 
pathophysiological, clinical and therapeutic features. Furthermore, 
epilepsy and migraine may mimic each other.
More than one hundred years later, in the era of digital EEG 
recordings, we can firmly report that sometimes “headache itself can 
even be epilepsy”, and, in certain cases (probably not recognized), “the 
headache can represent the only ictal epileptic phenomenon” [2,3]. 
In this regards, there have been proposed new criteria for the event 
termed “ictal epileptic headache” (IEH) in which “headache is the sole 
ictal epileptic manifestation” [4]. 
According to our recently proposed criteria for IEH, there are 
serious doubts about the real existence of the phenomenon called 
"migralepsy" [5,6]. This term, derived from migra(ine) and (epi)
lepsy, has been first used by Lennox and Lennox, in 1960 to describe 
a condition wherein “ophthalmic migraine with perhaps nausea and 
vomiting was followed by symptoms characteristic of epilepsy”.
Recent scientific evidences on the IEH, have convinced us that the 
“migralepsy” concept is exceptional or, even, it does not exist. In our 
opinion, the “migraine-epilepsy” sequence, defined as “migralepsy”, 
could simply be a seizure that starts with an “ictal headache”, and 
continues with a seizure (sensory-motor partial or generalized), fitting 
thus in these cases into codified criteria for “Hemicrania Epileptica” 
[7,8]. 
Moreover it is significant to underline that rarely in IEH cases, 
the headache ictal origin had been demonstrated (by chance in drug-
resistant epileptic patients, during pre-surgical investigations) only by 
deep electrode studies. In other words, while epileptiform abnormalities 
usually sustains a diagnosis of epilepsy, not rarely IEH patients are 
characterized by the absence of clear epileptic spike-and-wave activity. 
Missed recognitions of IEH events are due to these reasons [9,10]. 
Highlighted these aspects, the overlap between headache 
and epilepsy should be analyzed from multiple points of view: 
epidemiological, physiological, etiopathological, and classificative. 
Migraineurs show an higher frequency of epilepsy (range 1–17%) than 
general population (0.5–1%), and at the same time migraine prevalence 
among patients affected by epilepsy is also higher (range 8–15%) than 
that reported in healthy individuals [11-13]. Especially in children this 
comorbidity is found often [14].
Seizures and migraine attacks share different pathophysiological 
mechanisms. Both events may be sign of an underlying brain 
lesion, or have a probably genetic origin. In this respect, it has been 
shown that in epilepsy occurs hyperexcitation, while in migraine a 
brief hyperexcitation period (depolarization) is followed by a long 
hypoexcitation period (spreading depression), followed again by 
hyperexcitation, as rebound phenomenon. Moreover, it has been 
shown that a disexcitability (hyper- and hypo-excitation in the 
same migraineurs at different points in time) underlines both the 
phenomenon [1].
Cortical Spreading Depression (CSD) is believed to underlie both 
migraine and epilepsy [15,16], even in patients affected by migraine 
without aura. CSD is characterized by a slowly propagating wave of 
sustained strong neuronal depolarization that generates transient 
intense spike activity as it progresses into the brain tissue, followed 
by neural suppression which may last for minutes. The phase of 
depolarization is associated with a regional cerebral blood flow 
increase, whereas the phase of reduced neural activity is associated with 
a reduction in blood flow [17]. 
It is crucial to remark that while an epileptic discharge can origin 
exclusively in the cortex, the physiopathogenesis of headache has its 
origin at multiple cortico-subcortical levels. Thus, the two cascades 
of events (headache and epilepsy) show independent ways that can 
crossover only at the cortical level [18,19]. When headache and epilepsy 
overlap, after the cortical cascade of events, their onset and propagation 
are triggered when CSD and epileptic focus reach a definite threshold, 
lower for CSD than for seizure [6,8,20,21]. Moreover, the onset of CSD 
and that of the epileptic seizure may facilitate each other [22].
Triggering factors may be environmental or individual (genetically 
determined or not), determining an ions flow and leading to CSD, 
through neuronal and glial cytoplasmic bridges rather than through 
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interstitial spaces, as usually occurs in the spreading of epileptic 
seizures.
Strong support for a shared genetic basis between headache and 
epilepsy comes from clinical/EEG and genetic studies on familial 
hemiplegic migraine, a rare monogenic subtype of migraine [23-25], 
where errors in the same gene may be associated with migraine in some 
cases and with epilepsy in others [26]. 
Gene mutations have been found using positional cloning 
techniques, mutation analysis, and traditional linkage analysis which 
require testing several hundreds or thousands of genetic markers across 
the genome and selecting those chromosomal regions that most closely 
segregate with the disease. A second linkage analysis strategy is affected 
sib-pair analysis in which affected siblings shared chromosomal regions 
that occur with a probability higher than by chance alone are identified. 
Candidate genes in the shared regions are then characterized testing 
single-nucleotide polymorphism (SNPs). The objective is to identify 
SNPs, and thus gene alleles, whose frequency significantly differs 
between cases and controls and increases susceptibility to the disease. 
A third, hypothesis-driven approach is direct testing of candidate genes 
in case–control association studies [27].
Recent studies propose common genetic substrates and a correlatone 
between phenotypic and genotypic linked to mutations in some ion 
transporters genes, including CACNA1A, ATP1A2, and SCN1A [28-
32]. Other geneting findigs are reported in literature to explain the link 
between migraine and epilepsy. They include mutations on SLC1A3, a 
member of the solute carrier family that encodes excitatory amino acid 
transporter 1, 57 POLG58, C10 and F259, which encode mitochondrial 
DNA polymerase and helicase twinkle [33]. Recently numerous 
genome-wide association studies and meta-analysis are identifying loci 
associated migraine and epilepsy susceptibility [34].
The fundamentals of molecular genetics, are important for 
clinicians to understand unprecedented insights into the pathogenesis 
of these disorders, and reveal promising treatment targets for future 
drug development. Further genetic, experimental and clinical 
investigations (molecular and multicenter clinical trials) are necessary 
to better understand this complex relationship; this approach could be 
the basis to create a definitive international consensus on this matter.
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